NCT07286812 · NOT YET RECRUITING
Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
This study is testing whether a step-by-step screening approach using digital tools and blood markers can catch early signs of cognitive impairment more efficiently than traditional questionnaire-based methods. Researchers will analyze gait, facial expressions, and speech patterns alongside blood tests to build a predictive model for early diagnosis. The phase is unspecified, so this appears to be an observational or exploratory study, not a drug trial.
You may qualify if
- Adults aged 50 and above;
- Residents of this community for at least one year, with established medical records;
- Deny a history of cognitive impairment diseases (mild cognitive impairment, dementia, Alzheimer's, etc.) and the use of anti-dementia drugs (cholinesterase inhibitors or memantine, etc.);
- Agree to participate in the study;
- The individual and their relatives can communicate normally in Chinese.
You're excluded if
- Self-reported or confirmed through inquiry that there is a severe mental disorder, such as bipolar disorder or schizophrenia, etc.
- Suffering from a disease that makes it impossible to complete the cognitive assessment.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-12-16